Patient Safety Tool: Table of Standard Concentrations of Neonatal Drug Infusions
The Institute for Safe Medication Practices (ISMP) and Vermont Oxford Network have collaborated on a table of standard concentrations of neonatal drug infusions.
The table was developed with the assistance of representatives from U.S. neonatal intensive care units.
According to a description of the table, which is published on the ISMP website, the safety benefits of all hospitals using the same standard concentrations for neonates include the following:
- Reduce medication error risk when critically-ill neonates are transferred from one facility to another
- Stimulate development of standardized infusion device drug libraries
- Provide the demand necessary for manufacturers to offer commercially prepared standard solutions (if not already available), thereby reducing the risk of extemporaneous compounding errors within hospitals.
Download the table on standard concentrations of neonatal drug infusions (pdf).
Download other patient safety-related tools and resources:
© Copyright ASC COMMUNICATIONS 2016. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
- AGA to host drug development conference: 3 things to know
- MiraMed releases fall 2016 healthcare journal: 3 notes
- 4 key thoughts into physicians' ability to turn away unvaccinated children
- Federal officials are getting tough on Medicare fraud — 4 things to know
- The ACA's role in keeping Medicare viable — 3 insights